141 related articles for article (PubMed ID: 34279934)
1. Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer.
Zhang Z; Ghosh A; Connolly PJ; King P; Wilde T; Wang J; Dong Y; Li X; Liao D; Chen H; Tian G; Suarez J; Bonnette WG; Pande V; Diloreto KA; Shi Y; Patel S; Pietrak B; Szewczuk L; Sensenhauser C; Dallas S; Edwards JP; Bachman KE; Evans DC
J Med Chem; 2021 Aug; 64(15):11570-11596. PubMed ID: 34279934
[TBL] [Abstract][Full Text] [Related]
2. Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines.
Buzharevski A; Paskas S; Sárosi MB; Laube M; Lönnecke P; Neumann W; Mijatovic S; Maksimovic-Ivanic D; Pietzsch J; Hey-Hawkins E
ChemMedChem; 2019 Feb; 14(3):315-321. PubMed ID: 30602073
[TBL] [Abstract][Full Text] [Related]
3. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
Volpato M; Ingram N; Perry SL; Spencer J; Race AD; Marshall C; Hutchinson JM; Nicolaou A; Loadman PM; Coletta PL; Hull MA
Cancer Chemother Pharmacol; 2021 Feb; 87(2):173-184. PubMed ID: 33040178
[TBL] [Abstract][Full Text] [Related]
5. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
6. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
[TBL] [Abstract][Full Text] [Related]
7. Potent Phenylpyridine and Oxodihydrofuran Inhibitors of Cyclooxygenase-2: Optimization toward a Long Residence Time with Balanced Internal Energetics.
Tian G; Suarez J; Zhang Z; Connolly P; Ahn K
Biochemistry; 2021 Aug; 60(31):2407-2418. PubMed ID: 34293856
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Evaluation of an (18)F-Labeled Radiotracer Based on Celecoxib-NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase-2 (COX-2).
Kaur J; Tietz O; Bhardwaj A; Marshall A; Way J; Wuest M; Wuest F
ChemMedChem; 2015 Oct; 10(10):1635-40. PubMed ID: 26287271
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity.
Vahedpour T; Kaur J; Hemmati S; Hamzeh-Mivehroud M; Alizadeh AA; Wuest F; Dastmalchi S
Chem Biodivers; 2021 Mar; 18(3):e2000832. PubMed ID: 33620122
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells.
Huang J; Yuan X; Pang Q; Zhang H; Yu J; Yang B; Zhou L; Zhang F; Liu F
Drug Des Devel Ther; 2018; 12():2223-2231. PubMed ID: 30038488
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo.
Rahman M; Selvarajan K; Hasan MR; Chan AP; Jin C; Kim J; Chan SK; Le ND; Kim YB; Tai IT
Neoplasia; 2012 Jul; 14(7):624-33. PubMed ID: 22904679
[TBL] [Abstract][Full Text] [Related]
12. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
El-Sayed NA; Nour MS; Salem MA; Arafa RK
Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro and in silico evaluation of novel trans-stilbene analogues as potential COX-2 inhibitors.
Regulski M; Piotrowska-Kempisty H; Prukała W; Dutkiewicz Z; Regulska K; Stanisz B; Murias M
Bioorg Med Chem; 2018 Jan; 26(1):141-151. PubMed ID: 29191502
[TBL] [Abstract][Full Text] [Related]
14. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
Ghatak S; Vyas A; Misra S; O'Brien P; Zambre A; Fresco VM; Markwald RR; Swamy KV; Afrasiabi Z; Choudhury A; Khetmalas M; Padhye S
Bioorg Med Chem Lett; 2014 Jan; 24(1):317-24. PubMed ID: 24295787
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY.
Abdelall EKA; Lamie PF; Ali WAM
Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer.
Alqahtani AM; Chidambaram K; Pino-Figueroa A; Chandrasekaran B; Dhanaraj P; Venkatesan K
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1916-1927. PubMed ID: 33660801
[TBL] [Abstract][Full Text] [Related]
17. Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc
Hull MA; Cuthbert RJ; Ko CWS; Scott DJ; Cartwright EJ; Hawcroft G; Perry SL; Ingram N; Carr IM; Markham AF; Bonifer C; Coletta PL
Sci Rep; 2017 Jul; 7(1):6074. PubMed ID: 28729694
[TBL] [Abstract][Full Text] [Related]
18. c-Met inhibition is required for the celecoxib-attenuated stemness property of human colorectal cancer cells.
Lin YM; Lu CC; Hsiang YP; Pi SC; Chen CI; Cheng KC; Pan HL; Chien PH; Chen YJ
J Cell Physiol; 2019 Jul; 234(7):10336-10344. PubMed ID: 30480806
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.
Li Z; Wang ZC; Li X; Abbas M; Wu SY; Ren SZ; Liu QX; Liu Y; Chen PW; Duan YT; Lv PC; Zhu HL
Eur J Med Chem; 2019 May; 169():168-184. PubMed ID: 30877972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]